Valbonne, France

Daniel Asselineau

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignees: Centre International De Recherches Dermatologigues Galderma (Cird, Centre International De Recherches Dermatologiques. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Asselineau. Retrieved from https://idiyas.com/inventor/daniel-asselineau-mhw4z06c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Dermatology: The Contributions of Daniel Asselineau

Introduction

Daniel Asselineau, an accomplished inventor based in Valbonne, France, has made significant strides in the field of dermatology through his innovative inventions. With a total of two patents to his name, he has contributed to the development of advanced skin substitutes that offer promising solutions for skin regeneration and treatment.

Latest Patents

Among his latest inventions is a groundbreaking skin substitute that consists of a dermis equivalent covered with an epidermis equivalent. This innovative dermis equivalent is created from a type I collagen gel infused with fibroblasts, which play a crucial role in skin structure and healing. Furthermore, the epidermis equivalent includes a basal membrane equivalent, arranged basal layer cells connected to the membrane via hemidesmosomes, as well as cells from the suprabasal layers, granular cells, and keratinized cells positioned near the surface to enhance functionality and realism.

In addition, he developed a process for creating a skin substitute, involving the preparation of a dermis substitute by combining contractile cells with a nutritive medium and collagen, resulting in a contracting gel. This dermis substitute serves as a substrate for an epidermis substitute, which is developed using keratinocytes from human or animal skin samples. Notably, this innovative process involves the implantation of a hair follicle section, retaining its cellular sheath, into the substrate perpendicularly, further enhancing the potential efficacy of the skin substitute.

Career Highlights

Throughout his career, Daniel Asselineau has made notable contributions while working at the Centre International De Recherches Dermatologiques and the Centre International De Recherches Dermatologiques Galderma. His expertise in dermatology and innovative research has positioned him as a prominent figure in developing new skin treatments and solutions.

Collaborations

Daniel has collaborated with esteemed professionals in his field, including colleagues Bruno Bernard and Braham Shroot. These partnerships have been instrumental in advancing his research and achieving groundbreaking innovations in skin substitutes.

Conclusion

Daniel Asselineau's contributions to dermatology through his inventive patents exemplify the potential of innovations in enhancing skin treatment and regeneration. His work not only represents significant advancements in medical technology but also offers hope for improved therapeutic options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…